Medpage Today on MSN2d
More Thyroid Cancers Found After Starting GLP-1s: Researchers Think They Know Why
More thyroid cancers were detected soon after starting a GLP-1 receptor agonist than other diabetes drugs, a secondary ...
Medical News Today3d
GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, ...
Study of 2 million patients maps benefits and risks of new weight-loss drugs
GLP-1 medications associated with lower risks of Alzheimer's and heart disease, but higher risks of pancreatitis and kidney ...
Neuroscience News4d
GLP-1 Drugs Offer Brain Benefits but May Pose Other Health Risks
A study analyzing data from over 2 million veterans found that GLP-1 receptor agonists, popular weight-loss drugs like ...
Monthly Prescribing Reference2d
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders ...
Monthly Prescribing Reference1d
No Link Seen Between GLP-1 Receptor Agonist Use and Thyroid Cancer
HealthDay News — Glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is not associated with an increased risk for thyroid cancer over the short term, according to a study published online January ...